These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34173121)

  • 1. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
    Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
    Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature.
    Eid Y; Alves A; Lubrano J; Menahem B
    J Visc Surg; 2018 Dec; 155(6):445-452. PubMed ID: 29657063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study.
    Arezzo A; Lo Secco G; Passera R; Esposito L; Guerrieri M; Ortenzi M; Bujko K; Perez RO; Habr-Gama A; Stipa F; Picchio M; Restivo A; Zorcolo L; Coco C; Rizzo G; Mistrangelo M; Morino M
    Tech Coloproctol; 2019 Sep; 23(9):831-842. PubMed ID: 31388861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 6. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion total mesorectal excision following transanal endoscopic microsurgery does not compromise outcomes in patients with rectal cancer.
    Levic Souzani K; Bulut O; Kuhlmann TP; Gögenur I; Bisgaard T
    Surg Endosc; 2022 Feb; 36(2):1181-1190. PubMed ID: 33629183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer.
    Caycedo-Marulanda A; Lee L; Chadi SA; Verschoor CP; Crosina J; Ashamalla S; Brown CJ;
    JAMA Netw Open; 2021 Feb; 4(2):e2036330. PubMed ID: 33533932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early salvage total mesorectal excision (sTME) after organ preservation failure in rectal cancer does not worsen postoperative outcomes compared to primary TME: systematic review and meta-analysis.
    Chaouch MA; Khan J; Gill TS; Mehrabi A; Reissfelder C; Rahberi N; Elhadedy H; Oweira H
    Int J Colorectal Dis; 2021 Nov; 36(11):2375-2386. PubMed ID: 34244857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
    [No Abstract]   [Full Text] [Related]  

  • 11. Does transanal local resection increase morbidity for subsequent total mesorectal excision for early rectal cancer?
    Coton C; Lefevre JH; Debove C; Creavin B; Chafai N; Tiret E; Parc Y
    Colorectal Dis; 2019 Jan; 21(1):15-22. PubMed ID: 30300969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 14. Completion Total Mesorectal Excision After Transanal Local Excision of Early Rectal Cancer: A Systematic Review and Meta-analysis.
    Wyatt JNR; Powell SG; Altaf K; Barrow HE; Alfred JS; Ahmed S
    Dis Colon Rectum; 2022 May; 65(5):628-640. PubMed ID: 35143429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oncological results after transanal total mesorectal excision for rectal carcinoma.
    Hol JC; van Oostendorp SE; Tuynman JB; Sietses C
    Tech Coloproctol; 2019 Sep; 23(9):903-911. PubMed ID: 31599385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
    São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
    Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic Total Mesorectal Excision Following Transanal Endoscopic Microsurgery for Rectal Cancer.
    Issa N; Fenig Y; Gingold-Belfer R; Khatib M; Khoury W; Wolfson L; Schmilovitz-Weiss H
    J Laparoendosc Adv Surg Tech A; 2018 Aug; 28(8):977-982. PubMed ID: 29668359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).
    Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L
    Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.